KASL clinical practice guidelines: management of nonalcoholic fatty liver disease.
D000410:Alanine Transaminase / Q000032:analysis; D000428:Alcohol Drinking; D000975:Antioxidants / Q000627:therapeutic use; D001219:Aspartate Aminotransferases / Q000032:analysis; D054459:Elasticity Imaging Techniques; D002149:Energy Intake; D015444:Exercise; D005234:Fatty Liver / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy; D006801:Humans; D008111:Liver Function Tests; D008279:Magnetic Resonance Imaging; D065626:Non-alcoholic Fatty Liver Disease; D012307:Risk Factors; D014057:Tomography, X-Ray Computed; D014810:Vitamin E / Q000627:therapeutic use
D000975:Antioxidants; D014810:Vitamin E; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase
Fatty liver; Guidelines; Hepatic steatosis; Steatohepatitis